The clinical effects of high-volume spinal anaesthesia with bupivacaine 0.125% were studied in 30 patients presenting for postpartum sterilisation. Group A, Band C patients received 6, 8 and 10 ml of bupivacaine 0.125% respectively. Onset, duration and regression of sensory block and motor blockade, haemodynamic parameters and postoperative complications were studied. A sensory level ofT1O was reliably obtained in Group Band C but not in Group A. Similarly motor blockade was unreliable in Group A compared with Group B (P < 0.05) and Group C (P < 0.05). Two segment regression times were similar in all three groups. L 1 regression times were 47. 9, 94.3 and 99.0 minutes in Groups A, Band C respectively. The corresponding times for complete recovery of motor power were 120, 212.3 and 182. 7 minutes respectively (P < 0.01 when Group A compared to B and C). A significant incidence of high spinal anaesthesia occurred when 10 ml bupivacaine 0.125% was administered (P < 0.05 when compared with Group A). No patient experienced respiratory discomfort in spite of sensory levels of up to T1. Hypotension responded readily to intravenous fluids and small doses of ephedrine (three patients). Only one patient (Group A) developed a postdural puncture headache. In this study, high-volume spinal anaesthesia with bupivacaine 0.125% was found to be satisfactory for postpartum tuballigation. The optimal volume of bupivacaine 0.125% was 8 ml.
High-volume spinal anaesthesia resulted from studies on the use of 10 ml of bupivacaine 0.125% as an epidural test dose.' Administered intravenously, this dose resulted in no signs and symptoms. The effects of subarachnoid administration were then studied by simulating inadvertent spinal administration in patients presenting for urologica1 surgery and later in twenty patients presenting for caesarean section. 2 Intrathecal administration resulted in a sensory block which was rapid and reliable but at times too high. Motor blockade was complete and patients were haemodynamically stable. The incidence of postspinal headache was lower than anticipated.
These findings suggested that high-volume spinal anaesthesia with bupivacaine 0.125% was superior to conventional low-volume techniques, provided that the incidence of high blocks could be reduced. The aim of this study was therefore to determine whether the administration of lower volumes of bupivacaine 0.125% could provide equally effective spinal anaesthesia without unnecessarily high sensory levels. Thus the spread, duration and regression of spinal anaesthesia with 6 ml and 8 ml were contrasted with those effects using 10 ml of bupivacaine 0.125%.
Bupivacaine 0.125% is used primarily in labour pain relief. A secondary aim of this study was to determine if lower volumes ofbupivacaine 0.125% would provide definite signs of intrathecal administration such as complete motor blockade and a dense, widespread sensory block. The lowest volume of bupivacaine 0.125% required in an epidural test dose has not been determined.
METHOD
Thirty ASA I and 11 patients presenting for postpartum sterilisation within 36 hours of delivery were studied. Approval was obtained from the hospital Ethics Committee and written consent was obtained from every patient. Criteria for exclusion were the presence of spinal deformity, coagulopathies, frequent headache and frequent backache. Patients were randomized into Groups A, Band C, and received 6, 8 and 10 ml of bupivacaine 0.125% respectively. Randomization was achieved by allocating patients to Groups A, B and C consecutively.
All patients received O.SI ofHartmann's solution prior to spinal anaesthesia. Patients were placed in the left lateral position with maximal flexion of the spine. The second lumbar interspace was identified and subarachnoid spinal anaesthesia performed with a 2S-gauge spinal needle using the midline approach. Physiological saline was used to dilute O.S% bupivacaine to a 0.I2S% solution. No vasoconstrictor was added. The solution was administered at approximately 1 ml every S seconds without barbotage.
Sensory level was evaluated by pinprick at 3-minute intervals for the first 30 minutes, at S-minute intervals for the next 30 minutes and then at IS-minute intervals until the block had completely regressed. Open ligation using the modified Pomeroy technique commenced when the sensory level reached TIO.
A modified Bromage score was used to assess motor blockade of the lower limbs at similar time intervals. A score of 0 indicated full motor power while a score of 6 indicated complete motor blockade. For each limb, scoring was as follows: 1 for inability to flex hip with knee extended, 1 for inability to flex knee and 1 for inability to flex the ankle joint. In addition to scoring motor paralysis of the lower limbs, motor blockade was evaluated by paradoxical respiratory chest movements, hand movements (TI) and shoulder movements (CS).
Haemodynamic monitoring consisted of noninvasive blood pressure and heart rate monitoring. Noninvasive blood pressure and pulse rate were assessed at I-minute intervals for half an hour followed by 3-minute intervals.
Patients were monitored in the recovery room until the sensory block had completely regressed, motor blockade scored 0, and blood pressures and heart rates had returned to within 10% of normal and systolic pressures were greater than 90 mmHg. Patients were allowed to ambulate four hours after returning to the wards. Patients were interviewed on the third and seventh postoperative days for complications such as headache and backache. Patients who had already been discharged were interviewed by telephone. The following criteria were used to differentiate post-dural-puncture headaches from ordinary headaches: unlike any previous headache, initiated or worsened by the erect posture, occipital and nuchal distribution, relieved by lying supine, photophobia and improvement after abdominal compression. 3 Statistical analysis was performed using the t tests, analysis of variance for repeated measures, Wilcoxon's rank sum test and Fisher's exact test. All results are expressed as mean and standard deviation. P < 0.05 was considered as statistically significant.
RESULTS
The characteristics of the patients studied are shown in Table I . There were no statistical differences between the three groups with regard to age, weight and height. Figure 1 shows the spread of the maximum sensory block. Four patients in Group A did not attain a sensory level ofT 1 O. In contrast all patients in Groups Band C did (P < O.OS). On the other hand, no patient from Group A had a sensory block of T2 or higher as compared to one patient from Group B (P> 0.05) and four patients from Group C (P<0.05).
The duration for which the sensory block was above or at a particular level is displayed in Table 2 . The duration of anaesthesia at or above T 1 0 and Tl2 was significantly longer in Group B (P< 0.05) and Group C (P< 0.01) compared with Group A. The duration of T 1 0 block in Group B patients ranged from 44 to 135 minutes compared with 44 to 170 minutes in Group C. The range of durations of Tl2 block in groups Band C were 54 to 160 minutes and 74 to 177 minutes respectively.
Complete paralysis of the lower limbs occurred less frequently in Group A (P < 0.05) compared to Groups Band C ( Table 3 ). The duration of the motor blockade was also shorter than that of the other two groups (P< 0.01).
The onset times of the Tl 0 block, the highest sensory level and the maximum motor blockade are shown in Table 4 . The onset of maximum sensory block was significantly slower than that of the motor blockade. It must however be borne in mind that the motor blockade score used in this study did not objectively measure blockade at the lower thoracic levels and hence the apparently more rapid motor blockade.
Hypotension when defined as a systolic blood pressure of less than 80 mmHg occurred in two patients from Group B and one patient from Group C. This was easily reversed by intravenous fluids and small doses of ephedrine (5, 15 and 30mg) . The incidence and degree of hypotension was lower in Group A although this did not attain statistical significance.
Regression of the sensory and motor blocks are indicated in Table 5 . Two-segment regression times were similar in all three groups. The time taken for the block to regress from the highest sensory level to Lt (Lt regression time) was shorter in Group A compared with Group B (P < 0.05) and Group C (P< 0.01). There was no significant difference between Groups Band C. Recovery of full motor power was faster in Group A although this was not statistically significant.
Morbidity was relatively minor and no unexpected complication was encountered. The most common problem was that of backache (3, 5 and 4 from Groups A, Band C respectively). Three patients in Group A required general anaesthesia due to inadequate sensory levels. Of the remaining seven patients, two experienced some degree of pain during the procedure. Only one patient (Group A) experienced a post-dural-puncture headache. No patient vomited but one did experience mild nausea (Group C).
DISCUSSION
Bupivacaine was first used in spinal anaesthesia in 1966. 4 In 1987 Van Zundert and colleagues simulated accidental subarachnoid administration of an epidural test dose (10 ml of bupivacaine 0.125%) in ten patients requesting spinal anaesthesia for minor urological surgery.l This resulted in a reliable sensory block with complete motor paralysis of the lower limbs. There were no significant effects on the arterial blood pressure and heart rate. As bupivacaine 0.125% is used predominantly in labour pain relief, this study was repeated in twenty obstetric patients presenting for caesarean section. 2 Sensory block was rapid with the maximum sensory level at T2 (range C5 to T5). This contrasted greatly with a previous study in which the same dose of bupivacaine administered as a 0.5% solution resulted in several blocks that extended to Cl /C2. 5 A lower incidence of hypotension and post-spinal headache was also observed with the use ofbupivacaine 0.125%. Thus the possible benefits of high-volume spinal anaesthesia include a more predictable and reliable sensory block with less haemodynamic instability.
Studies directly addressing the question of volume on spinal anaesthesia have resulted in conflicting conclusions. Initially, Logan, McClure and Wildsmith observed that plain bupivacaine, when administered in a larger volume, resulted in greater CSF displacement and therefore greater unpredictability of the spread of spinal analgesia. 6 This was disputed by Nielsen et at. who found no significant difference in the clinical effects between bupivacaine 0.5% 3 ml and bupivacaine 0.25% 6 mU The effects of 12.5 mg of bupivacaine administered in volumes of 2.5 ml or 10 ml was studied by Van Zundert and deWolf. 8 They too found no difference in the extent of anaesthesia, degree of motor blockade or haemodynamic In some studies, the sensory level with 10 ml of bupivacaine 0.125% was at times unnecessarily high. In this study, a sensory level ofT2 and above was considered excessively high. Administration of 10 ml bupivacaine 0.125% produced a statistically significant number of excessively high blocks and we are therefore unable to support the view that this is an appropriate epidural test dose. Reduction of the dose to 6 ml however resulted in an unreliable sensory block (S4 to T4) making diagnosis of accidental intrathecal administration uncertain. Complete paralysis of the lower limbs serves as useful confirmatory evidence of intrathecal administration. Motor blockade of the lower limbs was not reliably elicited in patients receiving 6 ml of bupivacaine 0.125%.
No patient experienced respiratory distress resulting from motor blockade of the muscles of respiration which frequently accompanies high blocks. Objectively, even with sensory levels ofT2 and higher, no patient had paradoxical respiratory movements nor was any weakness of shoulder movements or handgrip detected. Possibly, differential blockade occurred at the upper thoracic levels leading to sensory but not motor blockade. This finding is consistent with earlier studies using bupivacaine 0.125%. High-volume spinal anaesthesia may therefore be advantageous when relatively high sensory levels are required.
Several factors alter the clinical effects of spinal anaesthesia and these may account for some of the differences found between various studies. The use of water as a diluent would render the local anaesthetic mixture hypobaric, therefore making spread of the local anaesthetic agent more posturedependent. Taivainen and colleagues interrupted a study on 8 ml bupivacaine 0.19% after obtaining a C2 block. 9 In their study, water was used as the diluent and the procedure was performed with the patient in the sitting position. Not surprisingly, the hypobaric mixture resulted in high sensory levels with an average maximum sensory level of Tt. Addition of adrenaline, phenylephrine, opioids and clonidine affect both the quality and duration of anaesthesia. [10] [11] [12] In conclusion, 0.125% bupivacaine is suitable for use in high-volume spinal anaesthesia resulting in a rapid, widespread and reliable sensory block.
Patients were comfortable in spite of high sensory blocks as complete motor blockade of the lower limbs was not accompanied by respiratory embarrassment. Hypotension was easily treated with intravenous fluids and small doses of ephedrine. Only one of the thirty patients studied developed a mild post-dural-puncture headache in this relatively high-risk group. The optimal volume is 8 ml, as 6 ml of 0.125% bupivacaine produces unreliable sensory and motor blockade, while 10 ml of 0.125% bupivacaine often results in excessively high sensory levels. Similarly 6 ml of 0.125% bupivacaine would not be reliable as an epidural test dose while 10 ml would be excessive. Further work is required to determine the optimal epidural test dose in pregnant patients.
